Our study found that GPR65, different from other types of cancer (colon cancer, pancreatic cancer, etc.), has a new expression feature in OS patients, and reveals that the low expression of GPR65 indicates poor prognosis in OS patients. This evidence concerns the gene GPR65 and pancreatic neoplasm.